Tag: biopharma
BD Biosciences collaborates with CSIR-IGIB to set up its first CoE...
The new CoE is designed to advance single-cell multiomics research by integrating BD’s Rhapsody™ Single Cell Analysis Solutions with IGIB’s capabilities in high-throughput next-generation sequencing (NGS) and bioinformatics
Lupin receives positive CHMP opinion for Biosimilar Ranibizumab
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A (VEGF-A)
Vyome reports positive final phase 2 results for VT-1953; Plans to...
Based on these positive Phase 2 results, the company plans to advance VT-1953 into a pivotal study following discussions with the FDA to seek approval to enter $1B potential addressable market opportunity
Bristol Myers Squibb launches Mosaic: Signals a new era for tech-accelerated...
Demonstrates leadership in AI driven pharma through Accenture partnership
Lupin Foundation earns CRISIL’s highest VO 1A rating for excellence in...
This distinction is testament to LHWRF’s dedication to excellence, transparency, and impact in the realm of social responsibility
Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell...
Collaboration to facilitate advanced biologics testing by providing HCP coverage, characterization and quantification assays, and related services to customers globally
Avantor showcases mission-critical biopharma solutions, deepens partnerships at CPHI & PMEC...
The company showcased its comprehensive portfolio of high purity materials, laboratory consumables, bioprocessing solutions, single use technologies, and digital platforms
CrisprBits raises USD 3 million to scale its CRISPR platforms for...
The new capital will be deployed to scale commercialization of the PathCrisp molecular diagnostics platform, augmenting manufacturing capacity for high-impact tests in human health
IPA’s 10th Advanced GMP Workshop calls for unified quality vision to...
The two-day virtual programme brought together more than 20 industry leaders, domain experts, and international regulators
AstraZeneca and Sun Pharma partner to help patients living with Hyperkalaemia...
This exclusive agreement is aimed at further accelerating availability of SZC, an innovative and highly effective treatment for Hyperkalaemia to more patients across India